| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/02/1999 | US5876749 Pharmaceutical composition |
| 03/02/1999 | US5876747 Liposome preferentially traveling to cardiac and skeletal muscles |
| 03/02/1999 | US5876746 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 03/02/1999 | US5876745 Laminate structure on support |
| 03/02/1999 | US5876744 Highly bioadhesive and mucoadhesive compositions containing polyvinyl alcohol, polycarbophil and biopolymer for the treatment of skin conditions and as vehicles for active ingredients |
| 03/02/1999 | US5876742 Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof |
| 03/02/1999 | US5876741 Drug delivery |
| 03/02/1999 | US5876721 Vaccines |
| 03/02/1999 | US5876710 Drug delivery; using a brominated benzamide compound |
| 03/02/1999 | US5876709 Ophthalmic composition containing active Vitamin D |
| 03/02/1999 | US5876700 Inhalation |
| 03/02/1999 | US5876696 Composition comprising a fluorine containing surfactant and perfluoropentane for ultrasound |
| 03/02/1999 | US5876208 Optionally crosslinkable coatings for orthodontic devices |
| 03/02/1999 | CA2062001C Stabilized pvp-i solutions |
| 02/28/1999 | CA2246224A1 Chroman derivative containing ophthalmic solution |
| 02/25/1999 | WO1999009149A1 Three-dimensional polymer matrices |
| 02/25/1999 | WO1999009142A1 Encapsulation of living tissue cells in a microsphere |
| 02/25/1999 | WO1999009066A1 Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents |
| 02/25/1999 | WO1999009037A1 Phospholipid analogue compounds |
| 02/25/1999 | WO1999008997A1 Novel lipopolyamines, and the preparation and use thereof |
| 02/25/1999 | WO1999008782A1 Process for preparation of vesicles |
| 02/25/1999 | WO1999008729A1 Loading and release of water-insoluble drugs |
| 02/25/1999 | WO1999008728A1 Composition and device for in vivo cartilage repair |
| 02/25/1999 | WO1999008718A2 Bioresorbable compositions for implantable prostheses |
| 02/25/1999 | WO1999008711A1 Lipid-polyamide conjugates and compositions for nucleic acid delivery |
| 02/25/1999 | WO1999008706A1 Recombinant porcine adenovirus vector |
| 02/25/1999 | WO1999008704A1 Method of protecting against chronic infections |
| 02/25/1999 | WO1999008691A2 Use of locally delivered metal ions for treatment of periodontal disease |
| 02/25/1999 | WO1999008684A2 Solutions containing azasteroids |
| 02/25/1999 | WO1999008683A1 Pharmaceutical compositions comprising cefuroxime axetil |
| 02/25/1999 | WO1999008666A2 Pharmaceutical composition comprising an azateroid |
| 02/25/1999 | WO1999008664A1 Support for patches and patches provided with the support |
| 02/25/1999 | WO1999008663A1 Parenteral pimaricin as treatment of systemic infections |
| 02/25/1999 | WO1999008662A1 Sustained release drug delivery system suitable for oral administration |
| 02/25/1999 | WO1999008661A1 Controlled release dosage forms containing water soluble drugs |
| 02/25/1999 | WO1999008660A1 Solid pharmaceutical dosage forms in form of a particulate dispersion |
| 02/25/1999 | WO1999008659A1 Process for improving flow and compression of tableting compositions |
| 02/25/1999 | WO1999008658A1 Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
| 02/25/1999 | WO1999008657A2 Self-binding shearform compositions |
| 02/25/1999 | WO1999008656A1 Antacid composition |
| 02/25/1999 | WO1999008655A1 Quick disintegrating tablets |
| 02/25/1999 | WO1999008651A1 Skin care compositions and use |
| 02/25/1999 | WO1999008649A2 Foaming skin cream |
| 02/25/1999 | WO1999008636A1 Collagen-base auxiliary agent for ophthalmic surgery |
| 02/25/1999 | WO1999008521A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 02/25/1999 | WO1999008500A2 New crystalline form of omeprazole |
| 02/25/1999 | WO1998052613A3 Method of administration for a therapeutic agent utilizing suitable forms of hyaluronic acid and combinations with electroporation |
| 02/25/1999 | WO1998051285A3 Cationic amphiphile formulations |
| 02/25/1999 | WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity |
| 02/25/1999 | WO1998005678A3 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 02/25/1999 | DE19736592A1 New macrocyclic tetraether lipid derivatives |
| 02/25/1999 | DE19736520A1 New adhesive plaster containing electronic information |
| 02/25/1999 | DE19736315A1 Active agent containing device, for dermal use |
| 02/25/1999 | DE19735776A1 New neutral or cationic phospholipid analogues |
| 02/25/1999 | CA2363810A1 New form of omeprazole |
| 02/25/1999 | CA2301292A1 Antacid composition |
| 02/25/1999 | CA2301282A1 Process for improving flow and compression of tableting compositions |
| 02/25/1999 | CA2301228A1 Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
| 02/25/1999 | CA2301065A1 Use of locally delivered metal ions for treatment of periodontal disease |
| 02/25/1999 | CA2300135A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 02/25/1999 | CA2298543A1 Loading and release of water-insoluble drugs |
| 02/25/1999 | CA2297240A1 Controlled release dosage forms containing water soluble drugs |
| 02/25/1999 | CA2295478A1 Parenteral pimaricin as treatment of systemic infections |
| 02/25/1999 | CA2295023A1 Solutions containing azasteroids |
| 02/25/1999 | CA2295016A1 Pharmaceutical composition |
| 02/25/1999 | CA2269039A1 Collagen-base auxiliary agent for ophthalmic surgery |
| 02/24/1999 | EP0897989A2 Vehicle for delivery of particles to a sample |
| 02/24/1999 | EP0897987A2 Secretion of human protein linked to gamma interferon signal peptide |
| 02/24/1999 | EP0897300A1 Treatment of pruritus with vitamin d and analogs thereof |
| 02/24/1999 | EP0897264A1 Natural antioxidant composition |
| 02/24/1999 | EP0794769A4 Method of drug delivery and coatings for use in the method |
| 02/24/1999 | EP0740547B1 Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes |
| 02/24/1999 | EP0729369A4 Method and apparatus for delivering oxygen into blood |
| 02/24/1999 | CN1209068A Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
| 02/24/1999 | CN1209059A Taxane compositions and method for producing same |
| 02/24/1999 | CN1209056A Stable topical compositions |
| 02/24/1999 | CN1208647A Medical ointment for treating vitiligo |
| 02/24/1999 | CN1208617A Nose drops |
| 02/24/1999 | CN1208613A Sustained release and implantation type doxorubicin medicine and method for preparing same |
| 02/24/1999 | CN1208612A Sustained release and implantation type methotrexate medicine and method for preparing same |
| 02/24/1999 | CN1208611A Sustained release and implantation type fluorouracil medicine and method for preparing same |
| 02/24/1999 | CN1208610A Sustained release and implantation type mitomycin medicine and method for preparing same |
| 02/24/1999 | CN1208609A Sustained release and implantation type antineoplasma medicine and method for preparing same |
| 02/24/1999 | CN1042198C Multile emulsions |
| 02/23/1999 | US5874481 Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents |
| 02/23/1999 | US5874469 Drug vehicle |
| 02/23/1999 | US5874455 Method for treatment of cataract with radical scavenger |
| 02/23/1999 | US5874450 Aqueous buffered solution having alkaline ph containing a sleep promoting amount of doxylamine and anionic surfactants selected from long chain hydrocarbon sulfonates or carboxylates |
| 02/23/1999 | US5874422 Reducing the drug side-effect while treating cardiovascular system disorder |
| 02/23/1999 | US5874418 Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
| 02/23/1999 | US5874408 Stabilized albumin-free recombinant factor VII preparation having a low sugar content |
| 02/23/1999 | US5874406 Synthetic peptide analogs of lung surface protein SP-C |
| 02/23/1999 | US5874112 Translucent antacid suspension |
| 02/23/1999 | US5874111 Process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles |
| 02/23/1999 | US5874110 Entrapping additives in carbohydrate bodies |
| 02/23/1999 | US5874109 Incorporation of biological molecules into bioactive glasses |
| 02/23/1999 | US5874108 Salt coated tablet |
| 02/23/1999 | US5874107 Sustained release tablet containing diclofenac-Na and methylhydroxypropyl-cellulose as a sustained release agent |
| 02/23/1999 | US5874106 Filled gelatin capsules |
| 02/23/1999 | US5874105 Lipid vesicles formed with alkylammonium fatty acid salts |